AMA1 binding peptide-based malaria vaccine (AdAlta)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAMA1 binding peptide-based malaria vaccine (AdAlta)

Drug Alias Nameapical membrane protein-1 binding peptide-based malaria vaccine (AdAlta)R1 malaria vaccine (AdAlta)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionApical membrane antigen 1 modulators

TargetsApical membrane antigen 1

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdAlta Pty Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAdAlta Pty Ltd

Active IndicationsN/A

Inactive IndicationsMalaria

ATC CodeN/A